Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications

In recent times, upconversion nanomaterials with mesoporous hollow structures have gained significant interest as a prospective nano-platform for cancer imaging and therapeutic applications. In this study, we report a highly biocompatible YVO<sub>4</sub>:1Er<sup>3+</sup>/10Yb...

Full description

Bibliographic Details
Main Authors: Eluri Pavitra, Hoomin Lee, Seung Kyu Hwang, Jin Young Park, Young-Kyu Han, Ganji Seeta Rama Raju, Yun Suk Huh
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/12/15/2520
_version_ 1797441198403616768
author Eluri Pavitra
Hoomin Lee
Seung Kyu Hwang
Jin Young Park
Young-Kyu Han
Ganji Seeta Rama Raju
Yun Suk Huh
author_facet Eluri Pavitra
Hoomin Lee
Seung Kyu Hwang
Jin Young Park
Young-Kyu Han
Ganji Seeta Rama Raju
Yun Suk Huh
author_sort Eluri Pavitra
collection DOAJ
description In recent times, upconversion nanomaterials with mesoporous hollow structures have gained significant interest as a prospective nano-platform for cancer imaging and therapeutic applications. In this study, we report a highly biocompatible YVO<sub>4</sub>:1Er<sup>3+</sup>/10Yb<sup>3+</sup> upconversion mesoporous hollow nanospheriods (YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs) by a facile and rapid self-sacrificing template method. The Rietveld analysis confirmed their pure phase of tetragonal zircon structure. Nitrogen adsorption–desorption isotherms revealed the mesoporous nature of these UC-MHNSPs and the surface area is found to be ~87.46 m<sup>2</sup>/g. Under near-infrared excitation (980 nm), YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs showed interesting color tunability from red to green emission. Initially (at 0.4 W), energy back transfer from Er<sup>3+</sup> to Yb<sup>3+</sup> ions leads to the strong red emission. Whereas at high pump powers (1 W), a fine green emission is observed due to the dominant three-photon excitation process and traditional energy transfer route from Er<sup>3+</sup> to Yb<sup>3+</sup> ions. The bright red light from the membrane of HeLa cells confirmed the effective cellular uptake of YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs. The resonant decrease in cell viability on increasing the concentration of curcumin conjugated YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs established their excellent antitumor activity. Therefore, the acquired results indicate that these YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs are promising drug carriers for bioimaging and various therapeutic applications.
first_indexed 2024-03-09T12:19:34Z
format Article
id doaj.art-1d4e969cd8c442e29b77b16e364c7d05
institution Directory Open Access Journal
issn 2079-4991
language English
last_indexed 2024-03-09T12:19:34Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj.art-1d4e969cd8c442e29b77b16e364c7d052023-11-30T22:41:52ZengMDPI AGNanomaterials2079-49912022-07-011215252010.3390/nano12152520Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic ApplicationsEluri Pavitra0Hoomin Lee1Seung Kyu Hwang2Jin Young Park3Young-Kyu Han4Ganji Seeta Rama Raju5Yun Suk Huh6Department of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, KoreaDepartment of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, KoreaDepartment of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, KoreaDepartment of Electrical, Electronics and Software Engineering, Pukyong National University, Yongdang Campus, Busan 48547, KoreaDepartment of Energy and Materials Engineering, Dongguk University-Seoul, Seoul 04620, KoreaDepartment of Energy and Materials Engineering, Dongguk University-Seoul, Seoul 04620, KoreaDepartment of Biological Engineering, Biohybrid Systems Research Center (BSRC), Inha University, Incheon 22212, KoreaIn recent times, upconversion nanomaterials with mesoporous hollow structures have gained significant interest as a prospective nano-platform for cancer imaging and therapeutic applications. In this study, we report a highly biocompatible YVO<sub>4</sub>:1Er<sup>3+</sup>/10Yb<sup>3+</sup> upconversion mesoporous hollow nanospheriods (YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs) by a facile and rapid self-sacrificing template method. The Rietveld analysis confirmed their pure phase of tetragonal zircon structure. Nitrogen adsorption–desorption isotherms revealed the mesoporous nature of these UC-MHNSPs and the surface area is found to be ~87.46 m<sup>2</sup>/g. Under near-infrared excitation (980 nm), YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs showed interesting color tunability from red to green emission. Initially (at 0.4 W), energy back transfer from Er<sup>3+</sup> to Yb<sup>3+</sup> ions leads to the strong red emission. Whereas at high pump powers (1 W), a fine green emission is observed due to the dominant three-photon excitation process and traditional energy transfer route from Er<sup>3+</sup> to Yb<sup>3+</sup> ions. The bright red light from the membrane of HeLa cells confirmed the effective cellular uptake of YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs. The resonant decrease in cell viability on increasing the concentration of curcumin conjugated YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs established their excellent antitumor activity. Therefore, the acquired results indicate that these YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> UC-MHNSPs are promising drug carriers for bioimaging and various therapeutic applications.https://www.mdpi.com/2079-4991/12/15/2520mesoporous hollow nanospheriodsUC luminescencecolor tunabilityfluorescence imagingantitumor activity
spellingShingle Eluri Pavitra
Hoomin Lee
Seung Kyu Hwang
Jin Young Park
Young-Kyu Han
Ganji Seeta Rama Raju
Yun Suk Huh
Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
Nanomaterials
mesoporous hollow nanospheriods
UC luminescence
color tunability
fluorescence imaging
antitumor activity
title Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
title_full Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
title_fullStr Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
title_full_unstemmed Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
title_short Evolution of Highly Biocompatible and Thermally Stable YVO<sub>4</sub>:Er<sup>3+</sup>/Yb<sup>3+</sup> Upconversion Mesoporous Hollow Nanospheriods as Drug Carriers for Therapeutic Applications
title_sort evolution of highly biocompatible and thermally stable yvo sub 4 sub er sup 3 sup yb sup 3 sup upconversion mesoporous hollow nanospheriods as drug carriers for therapeutic applications
topic mesoporous hollow nanospheriods
UC luminescence
color tunability
fluorescence imaging
antitumor activity
url https://www.mdpi.com/2079-4991/12/15/2520
work_keys_str_mv AT eluripavitra evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT hoominlee evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT seungkyuhwang evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT jinyoungpark evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT youngkyuhan evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT ganjiseetaramaraju evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications
AT yunsukhuh evolutionofhighlybiocompatibleandthermallystableyvosub4subersup3supybsup3supupconversionmesoporoushollownanospheriodsasdrugcarriersfortherapeuticapplications